The Bull’s-Eye Award for Innovation and Excellence in Immunization

The AIM Bull's Eye Award for Innovation and Excellence in Immunization is presented to a state, territorial or local (grantee) immunization program in recognition of an outstanding immunization initiative. The award recognizes immunization strategies that hit their mark and increase the awareness of successful immunization initiatives by encouraging replication in other programs.

Background and Award Information


2009 Winners

Winner! Hawaii’s Stop Flu at School program offers free influenza vaccine to children in grades K-8 at school-based clinics across the state. Nomination Narrative

Winner! Washington State’s Hib Shortage Vaccine Management Initiative created geographic vaccine allocations to assure balanced distribution of Hib vaccine and targeted high volume providers to receive the new and more readily available combination Hib vaccine product.  Nomination Narrative; Chart

Winner! Tennessee’s Pandemic Influenza Vaccine Pre-Registration system provided a no-obligation online registration process for providers to register for information and for the opportunity to order H1N1 vaccine.  Providers were first required to register as authorized users of the Tennessee Web Immunization System (TWIS), helping to increase use of the state’s immunization registry system.  Nomination Narrative

2009 Nominees

New York’s Online School Assessment System (OSAS) electronically collects immunization coverage data from schools, colleges and daycare centers to ensure compliance with state mandatory immunization laws. Nomination Narrative

Oklahoma’s Child Care Audit Program uses field consultants to visit child care centers and work directly with facility staff to improve immunization coverage rates and assure compliance with state mandatory immunization laws. Nomination Narrative

Minnesota’s Health Care Setting Influenza Vaccination Program conducted a survey of 280 facilities with healthcare personnel to assess coverage rates and evaluate the effectiveness of vaccination strategies such as onsite vaccination, no-cost vaccination, educational and promotional activities, and the use of declination forms. Nomination Narrative; Logic Model; Power Point Presentation

Washington State’s Initiative to Transition from Universal Purchase to HPV Select used a comprehensive communication and education strategy to prepare providers for change and worked with insurers and other stakeholders to provide insurance coverage for HPV vaccine and explore alternative funding mechanisms for vaccine in the future.  Nomination Narrative

Background and Award Information

Award Presentation: Bull's Eye Awards will be presented to three winning nominations. Winners will be recognized with a plaque and a $100 gift card at the opening plenary of the 2009 Program Managers Meeting (Monday, November 16). Winners will also be given the option to make a presentation on their award-winning initiative on the final day of the Program Managers Meeting (Wednesday, November 18).

Eligible Candidates: Recipients of the AIM Bull's Eye Award must be one of the 64 federally funded immunization grantee project areas, although the winning effort may be conducted in concert with other partners. A single project area may not receive more than one of the three awards in a particular year.

H1N1 Initiatives: Grantees are encouraged to submit nominations related to all aspects of H1N1 (vaccination, communications, antiviral distribution, community mitigation, etc.). Applicants should discuss effectiveness and/or expected effectiveness using any information available. Applications will not be penalized for lack of evaluation data.

Selection Criteria: Nominees will be judged based on their achievement in these areas:

Background Description (10 points)

  1. Brief Background on the immunization issues or problems addressed.
  2. Goal/major purpose of the program/initiative.
  3. Target population or audience.
  4. Annual budget and funding sources.
  5. Timing of the program/initiative.

Justification (90 points)

  1. Innovation (40 points)
    2. In what way is the project especially innovative? How is this project different from projects with a similar intent? What obstacles were overcome to implement this project?
  2. Effectiveness (30 points)
    3. Does the project achieve its stated goals? What makes this program effective? Is there data to support this conclusion? How is the program evaluated?
  3. Potential for replication (20 points)
    4. How can the program be replicated in other immunization programs? What limitations/obstacles might other programs encounter if they replicated the project?

Nomination Procedures: All submissions must be emailed to awards@immunizationmanagers.com by October 5, 2009, utilizing the format detailed on the 2009 AIM Bull's Eye Award Nomination Form.

Selection Procedures: Nominations will be reviewed and selections made by the AIM Bull's Eye Award Selection Committee: the AIM Nominations/Award/Membership Committee members, a representative of the AIM general membership, a member of the AIM Executive Committee, a representative of CDC/NCIRD, and a representative of the Association of State and Territorial Health Officials.

For more information: Contact Helen Fox Fields at aiminfo@comcast.net or 301-424-6080.